Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 1/2, First-in-Human, Open-Label, Dose Escalation and Expansion Study of STAR0602, a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule, in Subjects With Unresectable, Locally Advanced, or Metastatic Solid Tumors That Are Antigen-rich (START-001)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT05592626
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:27:36.735419+00:00
Published At
2025-07-09T00:00:00+00:00
Record Updated At
2025-07-09
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Advanced Solid Tumors", "Genital Neoplasm, Female", "Urogenital Neoplasms", "Lung Neoplasm", "Neoplasms by Site", "Papillomavirus Infection", "Epstein-Barr Virus Infections", "Carcinoma", "Neoplasms", "Vulvar Neoplasms", "Vulvar Diseases", "Abdominal Neoplasm"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-07-09"
protocolSection.identificationModule.nctId
"NCT05592626"
protocolSection.identificationModule.officialTitle
"A Phase 1/2, First-in-Human, Open-Label, Dose Escalation and Expansion Study of STAR0602, a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule, in Subjects With Unresectable, Locally Advanced, or Metastatic Solid Tumors That Are Antigen-rich (START-001)"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Advanced Solid Tumors (protocolSection.conditionsModule.conditions)
  • Genital Neoplasm, Female (protocolSection.conditionsModule.conditions)
  • Urogenital Neoplasms (protocolSection.conditionsModule.conditions)
  • Lung Neoplasm (protocolSection.conditionsModule.conditions)
  • Neoplasms by Site (protocolSection.conditionsModule.conditions)
  • Papillomavirus Infection (protocolSection.conditionsModule.conditions)
  • Epstein-Barr Virus Infections (protocolSection.conditionsModule.conditions)
  • Carcinoma (protocolSection.conditionsModule.conditions)
  • Neoplasms (protocolSection.conditionsModule.conditions)
  • Vulvar Neoplasms (protocolSection.conditionsModule.conditions)
  • Vulvar Diseases (protocolSection.conditionsModule.conditions)
  • Abdominal Neoplasm (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.